Meeting report: 26th International Conference on Antiviral Research

Area of Science:

• Virology
• Drug Discovery
• Medicinal Chemistry

Background:

• The 26th International Conference on Antiviral Research (ICAR) convened in San Francisco, May 11-15, 2013.
• The conference featured key lectures on antiviral drug development and research.
• A central theme was the legacy of Antonín Holý and his contributions to nucleotide analog antivirals.

Framework:

• Pioneering work on nucleotide analogs, exemplified by tenofovir, has revolutionized HIV and chronic hepatitis B treatment.
• Research presented included novel anti-HIV agents like CCR5 inhibitors and reverse transcriptase inhibitors.
• Computational tools, such as the NAOMI model, are being developed to predict antiviral activity.

Implementation:

• Discussions covered the development of countermeasures against severe dengue virus.
• The potential of targeting RNA virus capping and repair enzymes for therapeutic intervention was explored.
• Clinical updates included the status of anti-HCV compounds and single-tablet regimens for HIV.

Implications:

• The conference underscored the ongoing progress in antiviral research and drug design.
• New therapeutic strategies and drug targets are emerging for various viral infections.
• Advancements in computational modeling and drug delivery systems, like nanoparticles, show promise.